Skip to content

Key resources

  • Bibliography
    Bibliography
  • Health promotion
    Health promotion
  • Health practice
    Health practice
  • Programs
    Programs
  • Conferences
    Conferences
  • Courses
    Courses
  • Funding
    Funding
  • Jobs
    Jobs
  • Organisations
    Organisations
  • Health Services MapHealth Services Map
Australian Indigenous HealthBulletin Alcohol and other drugs knowledge centre Yarning Places
 
  • Home
    • » Key resources and services
      • » Programs and projects
        • » Monitoring Prevenar13 Impact on Otitis Media and Respiratory Pathogen Carriage

Monitoring Prevenar13 Impact on Otitis Media and Respiratory Pathogen Carriage

 

Overview

This project aims to monitor the impact of the vaccine Prevenar13 on otitis media among Aboriginal and Torres Strait Islander children in the Northern Territory and Western Australia in 2013.

Currently, Prevenar13 immunises against seven different types of bacteria which cause otitis media, but there are other types that are not immunised against, and the prevalence of these is increasing.

The objectives of this project are to:

This project is part of ongoing monitoring of Prevenar13 efficacy and is an initiative of the Menzies School of Health Research and Pfizer.

Abstract adapted from Menzies School of Health Research

Contacts

Menzies School of Health Research
Darwin (Royal Darwin Hospital Campus)
John Mathews Building
Building 58, Rocklands Drive
Tiwi NT 0810
PO Box 41096
Casuarina NT 0811
Ph: (08) 8946 8600
Fax: (08) 8946 8464
Email: operations@menzies.edu.au

Links

 
Last updated: 24 May 2017
 
Return to top